Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
PharmaForce 2016: September 12 – 14, 2016 | The Westin Princeton at Forrestal Village PharmaForce is the only event that brings together marketing and sales leaders for shared…
While a hologram will never completely replace the learning opportunities a cadaver affords, Microsoft is hopeful this technology will enhance any medical school experience.
Yao Shi, a graduate student research assistant at the University of Michigan, has developed an antenna capable of transmitting radio signals through body tissues up to 5 times…
Physicians can be considered medical artists, so Australian scientists are developing an advanced "paintbrush" for surgeons specializing in arthritis and joint replacements.
